Abstract
Poor sleep quality (SQ) is increasingly recognized as giving rise to decreased quality of life, and raising pain perception. Our aim is to evaluate the SQ in rheumatoid arthritis (RA) patients treated with anti-tumor necrosis factor alpha (anti-TNF-α) therapy. This was a prospective observational and open-label study of RA patients. A total of 35 patients with RA were enrolled in this study. Of the 35 patients, 22 had high disease activity (DA), and 13 were in remission. High DA group was initiated an anti TNF-α therapy. Clinical and objective parameters of SQ were assessed by using the Pittsburgh Sleep Quality Index (PSQI) and polysomnography (PSG). The total PSQI score and the frequency of poor SQ were high in 60 % of the RA patients. The median PSQI score was significantly higher in the high DA group than in the remission group (P = 0.026). Following an anti-TNF-α therapy initiation, significant improvements were observed in the high DA group by PSQI test (P = 0.012). However, no statistically significant difference was found by PSG (P > 0.05). Although an improvement in DA with anti-TNF-alpha therapy did not provide an amelioration in laboratory parameters, we found a significant improvement in SQ by subjective PSQI test. These findings may support that sleep disorders in RA are likely to be associated with a complex pathophysiology.
Similar content being viewed by others
References
Albani S, Carson D (1997) Etiology and pathogenesis of rheumatoid arthritis. Arthritis and allied conditions. Lippincott Williams & Wilkins, Baltimore MD, p. 979
McInnes IB, Schett G (2011) The pathogenesis of rheumatoid arthritis. N Engl J Med 365(23):2205–2219
Berry RB, Budhiraja R, Gottlieb DJ, Gozal D, Iber C, Kapur VK, et al. (2012) Rules for scoring respiratory events in sleep: update of the 2007 AASM manual for the scoring of sleep and associated events. J Clin Sleep Med 8(5):597–619
Opp M, Kapas L, Toth L (1992) Cytokine involvement in the regulation of sleep. Experimental Biology and Medicine 201(1):16–27
Vgontzas AN, Papanicolaou DA, Bixler EO, Lotsikas A, Zachman K, Kales A, et al. (1999) Circadian interleukin-6 secretion and quantity and depth of sleep. The Journal of Clinical Endocrinology & Metabolism 84(8):2603–2607
Mastorakos G, Chrousos GP, Weber JS (1993) Recombinant interleukin-6 activates the hypothalamic-pituitary-adrenal axis in humans. The Journal of Clinical Endocrinology & Metabolism 77(6):1690–1694
Isomäki P, Punnonen J (1997) Pro- and anti-inflammatory cytokines in rheumatoid arthritis. Ann Med 29(6):499–507
Drewes A (1999) Pain and sleep disturbances with special reference to fibromyalgia and rheumatoid arthritis. Rheumatology 38(11):1035–1038
Moldofsky H, Lue F, Smythe H (1983) Alpha EEG sleep and morning symptoms in rheumatoid arthritis. J Rheumatol 10(3):373–379
Gjevre JA, Taylor-Gjevre RM, Nair BV, Lim HJ (2012) Do sleepy rheumatoid arthritis patients have a sleep disorder? Musculoskeletal Care 10(4):187–195
Zamarron C, Maceiras F, Mera A, Gomez-Reino J (2004) Effect of the first infliximab infusion on sleep and alertness in patients with active rheumatoid arthritis. Ann Rheum Dis 63(1):88–90
Desai SB, Furst DE (2006) Problems encountered during anti-tumour necrosis factor therapy. Best Practice & Research Clinical Rheumatology 20(4):757–790
Aletaha D, Neogi T, Silman AJ, Funovits J, Felson DT, Bingham CO, et al. (2010) 2010 Rheumatoid arthritis classification criteria: an American College of Rheumatology/European league against rheumatism collaborative initiative. Arthritis & Rheumatism 62(9):2569–2581
Wells G, Becker J, Teng J, Dougados M, Schiff M, Smolen J, et al. (2009) Validation of the 28-joint disease activity score (DAS28) and European league against rheumatism response criteria based on C-reactive protein against disease progression in patients with rheumatoid arthritis, and comparison with the DAS28 based on erythrocyte sedimentation rate. Ann Rheum Dis 68(6):954–960
Prevoo M, Van’t Hof M, Kuper H, Van Leeuwen M, Van de Putte L, Van Riel P (1995) Modified disease activity scores that include twenty-eight-joint counts development and validation in a prospective longitudinal study of patients with rheumatoid arthritis. Arthritis & Rheumatism 38(1):44–48
Pinals RS, Masi AT, Larsen RA (1981) Preliminary criteria for clinical remission in rheumatoid arthritis. Arthritis & Rheumatism 24(10):1308–1315
Van Gestel A, Prevoo M, Van’t Hof M, Van Rijswijk M, Van de Putte L, Van Riel P (1996) Development and validation of the European league against rheumatism response criteria for rheumatoid arthritis: comparison with the preliminary American College of Rheumatology and the World Health Organization/International League Against Rheumatism criteria. Arthritis & Rheumatism 39(1):34–40
Fries JF, Spitz P, Kraines RG, Holman HR (1980) Measurement of patient outcome in arthritis. Arthritis & Rheumatism 23(2):137–145
Buysse DJ, Reynolds CF, Monk TH, Berman SR, Kupfer DJ (1989) The Pittsburgh Sleep Quality Index: a new instrument for psychiatric practice and research. Psychiatry Res 28(2):193–213
Agargun MY, Kara H, Anlar O (1996) Pittsburgh uyku kalitesi indeksinin geçerliliği ve güvenilirliği. Türk Psikiyatri Dergisi
Ohayon MM, Roth T (2002) Prevalence of restless legs syndrome and periodic limb movement disorder in the general population. J Psychosom Res 53(1):547–554
Bekci TT, Kayrak M, Kiyici A, Ari H, Teke T, Maden E, et al. (2012) The relation between Lp-PLA2 levels with periodic limb movements. Sleep and Breathing 16(1):117–122
Laureys S, Tononi G (2011) The neurology of consciousness: cognitive neuroscience and neuropathology: Academic Press
Spriggs WH (2014) Essentials of polysomnography: Jones & Bartlett Publishers
Solak Ö, Dündar Ü, Demirdal ÜS, Fidan F, Gökçe Ġ, Ünlü M (2009) Romatoid artrit hastalarının pittsburgh uyku kalite indeksi ile değerlendirilmesi. Türk Fiz Tıp Rehab Derg 55:107–101
Løppenthin K, Esbensen B, Jennum P, Østergaard M, Tolver A, Thomsen T, et al (2015) Sleep quality and correlates of poor sleep in patients with rheumatoid arthritis. Clinical rheumatology. 1–11.
Sariyildiz MA, Batmaz I, Bozkurt M, Bez Y, Cetincakmak MG, Yazmalar L, et al. (2014) Sleep quality in rheumatoid arthritis: relationship between the disease severity, depression, functional status and the quality of life. Journal of clinical medicine research 6(1):44
Luyster FS, Chasens ER, Wasko MCM, Dunbar-Jacob J (2011) Sleep quality and functional disability in patients with rheumatoid arthritis. Journal of clinical sleep medicine: JCSM: official publication of the American Academy of Sleep Medicine 7(1):49
Wells G, Li T, Tugwell P (2010) Investigation into the impact of abatacept on sleep quality in patients with rheumatoid arthritis, and the validity of the MOS-sleep questionnaire sleep disturbance scale. Ann Rheum Dis 69(10):1768–1773
Drewes AM, Svendsen L, Taagholt SJ, Bjerregård K, Nielsen KD, Hansen B (1998) Sleep in rheumatoid arthritis: a comparison with healthy subjects and studies of sleep/wake interactions. Rheumatology 37(1):71–81
Mahowald MW, Mahowald ML, Bundlie SR, Ytterberg SR (1989) Sleep fragmentation in rheumatoid arthritis. Arthritis & Rheumatism 32(8):974–983
Vgontzas A, Zoumakis E, Lin H-M, Bixler E, Trakada G, Chrousos G (2004) Marked decrease in sleepiness in patients with sleep apnea by etanercept, a tumor necrosis factor-α antagonist. The Journal of Clinical Endocrinology & Metabolism 89(9):4409–4413
Abad VC, Sarinas PS, Guilleminault C. Sleep and rheumatologic disorders. Sleep Med Rev. 2008;12(3):211–28.
Taylor-Gjevre RM, Gjevre JA, Skomro RP, Nair BV, Lim HJ (2011) Improved sleep efficiency after anti-tumor necrosis factor α therapy in rheumatoid arthritis patients. Therapeutic advances in musculoskeletal disease 3(5):227–233
Zamarrón C, Maceiras F, González J, Gómez-Reino JJ (2004) Worsening of obstructive sleep apnoeas in a patient with rheumatoid arthritis treated with anti-tumor necrosis factor. Respir Med 98(2):123–125
Coito AL, Belo D, Paiva T, Sanches JM, editors (2011) Topographic EEG brain mapping before, during and after obstructive sleep apnea episodes. Biomedical imaging: from nano to macro, 2011 I.E. International Symposium on; IEEE
Shoda N, Seichi A, Takeshita K, Chikuda H, Ono T, Oka H, et al. (2009) Sleep apnea in rheumatoid arthritis patients with occipitocervical lesions: the prevalence and associated radiographic features. Eur Spine J 18(6):905–910
Berger K, Luedemann J, Trenkwalder C, John U, Kessler C (2004) Sex and the risk of restless legs syndrome in the general population. Arch Intern Med 164(2):196–202
Phillips B, Young T, Finn L, Asher K, Hening WA, Purvis C (2000) Epidemiology of restless legs symptoms in adults. Arch Intern Med 160(14):2137–2141
Wollina U, Ständer K, Barta U (2001) Toxicity of methotrexate treatment in psoriasis and psoriatic arthritis–short-and long-term toxicity in 104 patients. Clin Rheumatol 20(6):406–410
Murphy PJ, Badia P, Myers BL, Boecker MR, Wright KP. Nonsteroidal anti-inflammatory drugs affect normal sleep patterns in humans. Physiol Behav. 1994;55(6):1063–6.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Disclosures
None.
Rights and permissions
About this article
Cite this article
Karatas, G., Bal, A., Yuceege, M. et al. The evaluation of sleep quality and response to anti-tumor necrosis factor α therapy in rheumatoid arthritis patients. Clin Rheumatol 36, 45–50 (2017). https://doi.org/10.1007/s10067-016-3387-6
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10067-016-3387-6